Currently, immunotherapy, popularly known as “immune checkpoint inhibitor therapy,” mainly refers to a strategy of empowering CD8+, cytotoxic Tc cells of the adaptive immune system to eliminate cancer cells [48]. The gene discussed is CD8A; the disease is cancer.